The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-20 of 32 articles
Thermodilution-derived volumetric resting coronary blood flow measurement in humans
Gallinoro E,
Candreva A,
Colaiori I,
Kodeboina M,
Fournier S,
Nelis O,
Di Gioia G,
Sonck J,
van 't Veer M,
Pijls N,
Collet C,
De Bruyne B
October 1, 2021 | 10.4244/EIJ-D-20-01092
Normal values of thermodilution-derived absolute coronary blood flow and microvascular resistance in humans
Fournier S,
Keulards D,
van 't Veer M,
Colaiori I,
Di Gioia G,
Zimmermann F,
Mizukami T,
Nagumo S,
Kodeboina M,
El Farissi M,
Zelis J,
Sonck J,
Collet C,
Pijls N,
De Bruyne B
July 20, 2021 | 10.4244/EIJ-D-20-00684
Selective intracoronary hypothermia in patients with ST-elevation myocardial infarction. Rationale and design of the EURO-ICE trial
El Farissi M,
Keulards D,
van 't Veer M,
Zelis J,
Berry C,
De Bruyne B,
Engstrøm T,
Fröbert O,
Piroth Z,
Oldroyd K,
Tonino P,
Pijls N,
Otterspoor L
April 20, 2021 | 10.4244/EIJ-D-19-00471
Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system
Verheye S,
Vrolix M,
Montorfano M,
Zivelonghi C,
Giannini F,
Bedogni F,
Dubois C,
De Bruyne B,
Costa R,
Chamié D,
de Ribamar Costa J,
Kereiakes D,
Abizaid A,
Colombo A
December 18, 2020 | 10.4244/EIJ-D-20-00763
Steady-state hyperaemia: many routes, one goal
September 18, 2020 | 10.4244/EIJV16I7A98
Procedural microvascular activation in long lesions treated with bioresorbable vascular scaffolds or everolimus-eluting stents: the PROACTIVE trial
Pellicano M,
Di Gioia G,
Ciccarelli G,
Xaplanteris P,
Delrue L,
Toth G,
Van Durme F,
Heyse A,
Wyffels E,
Vanderheyden M,
Bartunek J,
De Bruyne B,
Barbato E
June 12, 2020 | 10.4244/EIJ-D-18-01138
Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trial
Toth G,
De Bruyne B,
Kala P,
Ribichini F,
Casselman F,
Ramos R,
Piroth Z,
Fournier S,
Piccoli A,
van Mieghem C,
Penicka M,
Mates M,
Nemec P,
Van Praet F,
Stockman B,
Degriek I,
Barbato E
December 6, 2019 | 10.4244/EIJ-D-19-00463
Qualitative resting coronary pressure wave form analysis to predict fractional flow reserve
Matsumura M,
Maehara A,
Johnson N,
Fearon W,
De Bruyne B,
Oldroyd K,
Pijls N,
Jenkins P,
Ali Z,
Mintz G,
Stone G,
Jeremias A
February 7, 2019 | 10.4244/EIJ-D-17-01149
Coronary lesion progression as assessed by fractional flow reserve (FFR) and angiography
Xaplanteris P,
Ntalianis A,
De Bruyne B,
Strisciuglio T,
Pellicano M,
Ciccarelli G,
Milkas A,
Barbato E
October 19, 2018 | 10.4244/EIJ-D-17-00872
Validation of a novel non-hyperaemic index of coronary artery stenosis severity: the Resting Full-cycle Ratio (VALIDATE RFR) study
Svanerud J,
Ahn J,
Jeremias A,
van 't Veer M,
Gore A,
Maehara A,
Crowley A,
Pijls N,
De Bruyne B,
Johnson N,
Hennigan B,
Watkins S,
Berry C,
Oldroyd K,
Park S,
Ali Z
September 20, 2018 | 10.4244/EIJ-D-18-00342
Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months
Serruys P,
Onuma Y,
Garcia-Garcia H,
Muramatsu T,
van Geuns R,
De Bruyne B,
Dudek D,
Thuesen L,
Smits P,
Chevalier B,
McClean D,
Koolen J,
Windecker S,
Whitbourn R,
Meredith I,
Dorange C,
Veldhof S,
Hebert K,
Rapoza R,
Ormiston J
March 20, 2014 | 10.4244/EIJV9I11A217
The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials
Gogas B,
Bourantas C,
Garcia-Garcia H,
Onuma Y,
Muramatsu T,
Farooq V,
Diletti R,
van Geuns R,
De Bruyne B,
Chevalier B,
Thuesen L,
Smits P,
Dudek D,
Koolen J,
Windecker S,
Whitbourn R,
McClean D,
Dorange C,
Miquel-Hebert K,
Veldhof S,
Rapoza R,
Ormiston J,
Serruys P
October 25, 2013 | 10.4244/EIJV9I6A115
Age- and gender-related changes in plaque composition in patients with acute coronary syndrome: the PROSPECT study
Ruiz-Garc J,
Lerman A,
Weisz G,
Maehara A,
Mintz G,
Fahy M,
Xu K,
Lansky AJ,
Cristea E,
Farah T,
Teles R,
Bøtker H,
Templin B,
Zhang Z,
De Bruyne B,
Serruys P,
Stone G
December 28, 2012 | 10.4244/EIJV8I8A142
A prospective randomised comparison of titanium-nitride-oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: the BASE-ACS trial
Karjalainen P,
Niemelä M,
Airaksinen J,
Rivero-Crespo F,
Romppanen H,
Sia J,
Lalmand J,
De Bruyne B,
de Belder A,
Carlier M,
Nammas W,
Ylitalo A,
Hess O
July 27, 2012 | 10.4244/EIJV8I3A49
Latest news
AHEAD OF PRINT
Delayed hospitalisation in the MITRA-FR trial
FREE ARTICLE - Guillaume Leurent et al
May 25, 2022
EUROPCR LATE BREAKING
EuroPCR 2022 Late-breaking publications: watch the interviews with the authors!
May 23, 2022
NEW ISSUE
TAVI vs SAVR for bicuspid anatomies; PVR and TAVI; LAA thrombus trapping; crush techniques for bifurcation PCIs; stent elongation in POT and more
May 18, 2022
AHEAD OF PRINT
Complete cerebral protection during TAVI
FREE ARTICLE - Dariusz Jagielak et al
May 24, 2022
AHEAD OF PRINT
Outcomes of PCI for stent thrombosis
FREE ARTICLE - Mohamed O. Mohamed et al
May 24, 2022
EUROPCR LATE BREAKING
Changes in voice patterns for monitoring heart failure deterioration
FREE ARTICLE - Chaim Lotan et al
May 24, 2022
EUROPCR LATE BREAKING
SavvyWire in TAVI
FREE ARTICLE - Josep Rodés-Cabau et al
May 24, 2022